Literature DB >> 20106936

A proposed method to adjust for selection bias in cohort studies.

Anna Törner1, Ann-Sofi Duberg, Paul Dickman, Ake Svensson.   

Abstract

Selection bias is a concern in cohort studies in which selection into the cohort is related to the studied outcome. An example is chronic infection with hepatitis C virus, where the initial infection may be asymptomatic for decades. This problem leads to selection of more severely ill individuals into registers of such infections. Cohort studies often adjust for this bias by introducing a time window between entry into the cohort and entry into the study. This paper describes and assesses a novel method to improve adjustment for this type of selection bias. The size of the time window is decided by calculating a standardized incidence ratio as a continuous function of the size of the time window. The resulting graph is used to decide on an appropriate window size. The method is evaluated by using the Swedish register of hepatitis C virus infections for 1990-2006. The complications studied were non-Hodgkin lymphoma and liver cancer. Selection bias differed for the studied outcomes, and a time window of a minimum of 2 months and 12 months, respectively, was judged to be appropriate. The novel method may have advantages compared with an interval-based method, especially in cohort studies with small numbers of events.

Entities:  

Mesh:

Year:  2010        PMID: 20106936     DOI: 10.1093/aje/kwp432

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden.

Authors:  Jonathan N Hofmann; Anna Törner; Wong-Ho Chow; Weimin Ye; Mark P Purdue; Ann-Sofi Duberg
Journal:  Eur J Cancer Prev       Date:  2011-07       Impact factor: 2.497

2.  Assessing the first wave of epidemiological studies of nanomaterial workers.

Authors:  Saou-Hsing Liou; Candace S J Tsai; Daniela Pelclova; Mary K Schubauer-Berigan; Paul A Schulte
Journal:  J Nanopart Res       Date:  2015-10-19       Impact factor: 2.253

3.  Mortality among British Columbians testing for hepatitis C antibody.

Authors:  Amanda Yu; John J Spinelli; Darrel A Cook; Jane A Buxton; Mel Krajden
Journal:  BMC Public Health       Date:  2013-04-02       Impact factor: 3.295

4.  Assessing generalisability through the use of disease registers: findings from a diabetes cohort study.

Authors:  Michael David; Robert Ware; Maria Donald; Rosa Alati
Journal:  BMJ Open       Date:  2011-08-27       Impact factor: 2.692

5.  Area disease estimation based on sentinel hospital records.

Authors:  Jin-Feng Wang; Ben Y Reis; Mao-Gui Hu; George Christakos; Wei-Zhong Yang; Qiao Sun; Zhong-Jie Li; Xiao-Zhou Li; Sheng-Jie Lai; Hong-Yan Chen; Dao-Chen Wang
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

6.  Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study.

Authors:  Yoo Ri Chung; Kyoung Hwa Ha; Hyeon Chang Kim; Sang Jun Park; Kihwang Lee; Dae Jung Kim
Journal:  Diabetes Metab J       Date:  2019-02-20       Impact factor: 5.376

7.  Longitudinal follow-up of health effects among workers handling engineered nanomaterials: a panel study.

Authors:  Wei-Te Wu; Lih-Ann Li; Tsui-Chun Tsou; Shu-Li Wang; Hui-Ling Lee; Tung-Sheng Shih; Saou-Hsing Liou
Journal:  Environ Health       Date:  2019-12-09       Impact factor: 5.984

8.  Survival nomogram for different grades of gastric cancer patients based on SEER database and external validation cohort.

Authors:  Lei Hu; Kang Yang; Yue Chen; Chenyu Sun; Xu Wang; Shaopu Zhu; Shiyi Yang; Guodong Cao; Maoming Xiong; Bo Chen
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

9.  Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.

Authors:  Maryam Alavi; Jason Grebely; Behzad Hajarizadeh; Janaki Amin; Sarah Larney; Matthew G Law; Jacob George; Louisa Degenhardt; Gregory J Dore
Journal:  BMC Infect Dis       Date:  2018-05-09       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.